In this Aug. 25, 2016 file photo, Democratic presidential nominee Hillary Clinton speaks in Reno, Nev. Following the public outcry over steep increases in price for an emergency allergy treatment, Clinton is pledging to better protect patients from such costs.
Heather Bresch, the Mylan CEO under fire for skyrocketing EpiPen costs, believes Americans should redirect their anger toward a "broken" health care system. Mylan was forced to respond to the national outrage over a more than 400% increase in price for the lifesaving allergy treatment by pledging on Thursday to make it more affordable.
Democratic presidential candidate Hillary Clinton called on pharmaceutical company Mylan NV to voluntarily drop the price of its severe allergy treatment drug EpiPen, which has increased in price by more than 400 percent in the past decade. "That's outrageous - and it's just the latest troubling example of a company taking advantage of its consumers," Clinton said in a statement.